M. Dahl
发表
J. Ormiston,
P. Gladding,
M. Webster,
2008,
JACC. Cardiovascular interventions.
B. Williams-Jones,
T. Someya,
A. Gunes,
2006,
Pharmacogenomics.
M. Dahl,
M. G. Scordo,
Mao Mao,
2012,
Journal of clinical psychopharmacology.
R. Berecz,
A. Llerena,
M. Dahl,
2003,
European Journal of Clinical Pharmacology.
CYP2D6 and adjuvant tamoxifen: possible differences of outcome in pre- and post-menopausal patients.
S. Margolin,
J. Lindh,
Hanjing Xie,
2013,
Pharmacogenomics.
L. Gustafsson,
J. Eriksen,
M. Dahl,
2017,
PloS one.
S. Koch,
Dina Demner-Fushman,
P. Hjemdahl,
2020,
Expert review of clinical pharmacology.
M. Ingelman-Sundberg,
E. Albano,
I. Johansson,
1997,
Molecular pharmacology.
M. Ingelman-Sundberg,
L. Bertilsson,
I. Johansson,
1993
.
O. Andreassen,
E. Molden,
O. Spigset,
2017,
CNS Drugs.
J. Franck,
M. Dahl,
O. Beck,
2019,
Drug testing and analysis.
U. Yasar,
M. Babaoğlu,
M. Dahl,
2004,
European Journal of Clinical Pharmacology.
M. Dahl,
E. Skogh,
M. Josefsson,
2010,
Journal of pharmaceutical and biomedical analysis.
M. Karlsson,
M. Dahl,
R. Sandström,
2008,
Clinical pharmacology and therapeutics.
L. Meurling,
J. Lindh,
M. Dahl,
2003,
European Journal of Clinical Pharmacology.
L. Bertilsson,
A. Llerena,
U. Bondesson,
1994,
British journal of clinical pharmacology.
L. Bertilsson,
M. Dahl,
G. Tybring,
1995,
British journal of clinical pharmacology.
G. Sydsjö,
A. Josefsson,
M. Wadelius,
2004,
Nordic journal of psychiatry.
S. Fallarini,
G. Lombardi,
M. Dahl,
2020
.
M. Dahl,
T. Taiminen,
R. Salokangas,
1997,
The Journal of international medical research.
A. Llerena,
M. Dahl,
F. Sjöqvist,
1995,
British journal of clinical pharmacology.
B. Wettermark,
A. Llerena,
M. Dahl,
2000
.
P. Fernández-Salguero,
R. Berecz,
A. Llerena,
2003,
European Journal of Clinical Pharmacology.
K. Hedenmalm,
M. Dahl,
A. G. Granberg,
2014,
European Journal of Clinical Pharmacology.
A. Avenoso,
E. Spina,
I. Johansson,
1999,
Psychopharmacology.
K. Melkersson,
A. Gunes,
M. Dahl,
2007,
The Journal of clinical psychiatry.
C. Alm,
L. Bertilsson,
C. Elwin,
1997
.
L. Bertilsson,
M. Dahl,
G. Tybring,
2000,
Gastroenterology.
Yuan Zhang,
L. Bertilsson,
T. Andersson,
1992,
Pharmacogenetics.
J. Ormiston,
P. Gladding,
M. Webster,
2008,
JACC. Cardiovascular interventions.
B. Winblad,
M. Viitanen,
L. Lannfelt,
1998
.
R. Malmström,
J. Lindh,
M. Dahl,
2013,
European Journal of Clinical Pharmacology.
C. Alm,
L. Bertilsson,
A. Llerena,
1994,
British journal of clinical pharmacology.
M. Dahl,
E. Skogh,
M. Josefsson,
2011,
Journal of clinical psychopharmacology.
L. Bertilsson,
I. Johansson,
M. Dahl,
1995,
Pharmacogenetics.
M. Ingelman-Sundberg,
I. Johansson,
M. Dahl,
1996,
Pharmacogenetics.
L. Bertilsson,
M. Dahl,
1993,
Pharmacogenetics.
T. Marandi,
M. Dahl,
F. Sjöqvist,
1996,
Pharmacology & toxicology.
L. Bertilsson,
M. Dahl,
F. Sjöqvist,
1996,
Clinical pharmacology and therapeutics.
C. Alm,
L. Bertilsson,
C. Elwin,
1994,
Clinical pharmacology and therapeutics.
M. Ingelman-Sundberg,
L. Bertilsson,
I. Johansson,
1994,
EXS.
A. Llerena,
I. Johansson,
M. Dahl,
1993,
Clinical pharmacology and therapeutics.
E. Molden,
M. Dahl,
T. Haslemo,
2013,
Pharmacogenetics and genomics.
L. Bertilsson,
M. Dahl,
P. Dalén,
2000,
British journal of clinical pharmacology.
L. Bertilsson,
M. Dahl,
C. Nordin,
1996,
Psychopharmacology.
M. Dahl,
G. Tybring,
I. Bertilsson,
1997,
Acta psychiatrica Scandinavica. Supplementum.
L. Bertilsson,
H. Yamada,
M. Dahl,
1996,
Pharmacogenetics.
K. Melkersson,
M. Dahl,
2003,
Psychopharmacology.
M. Ingelman-Sundberg,
I. Johansson,
M. Dahl,
1992,
Clinical pharmacology and therapeutics.
L. Bertilsson,
E. Spina,
I. Johansson,
2000,
European Journal of Clinical Pharmacology.
M. Dahl,
F. Sjöqvist,
B. Siwers,
1995,
Journal of clinical psychopharmacology.
J. Lindh,
M. Dahl,
Ming Chang,
2014,
Clinical Pharmacokinetics.
M. Ingelman-Sundberg,
L. Bertilsson,
I. Johansson,
1992,
Pharmacogenetics.
M. Dahl,
O. Beck,
G. Ackehed,
2019,
European Journal of Clinical Pharmacology.
M. Eriksson,
M. Dahl,
C. Nordin,
1997,
The Lancet.
P. Hartvig,
M. Wadelius,
L. Lindström,
2008,
Journal of psychiatric research.
E. Perucca,
E. Spina,
M. Dahl,
2005,
Basic & clinical pharmacology & toxicology.
O. Spigset,
K. Hedenmalm,
M. Dahl,
2006,
Journal of clinical psychopharmacology.
J. Ormiston,
P. Gladding,
M. Webster,
2008,
JACC. Cardiovascular interventions.
C. Masimirembwa,
A. Matimba,
A. Gunes,
2009,
Pharmacogenomics.
Erkan Cüre,
A. Gunes,
M. Dahl,
2011,
European Journal of Clinical Pharmacology.
U. Yasar,
M. Dahl,
E. Eliasson,
2002,
British journal of clinical pharmacology.
E. Kalso,
P. Neuvonen,
V. Kontinen,
2010,
Scandinavian journal of pain.
C. Halldin,
S. Nyberg,
M. Dahl,
1995,
Psychopharmacology.
L. Bertilsson,
M. Dahl,
J. Widén,
1991,
Acta psychiatrica Scandinavica.
L. Bertilsson,
Chang-Shin Park,
M. Dahl,
2001,
British journal of clinical pharmacology.
C. Alm,
M. Ingelman-Sundberg,
L. Bertilsson,
1999,
Pharmacogenetics.
L. Bertilsson,
K. Otani,
S. Kaneko,
1997,
Journal of clinical psychopharmacology.
L. Bertilsson,
A. Llerena,
M. Dahl,
1992,
Therapeutic drug monitoring.
L. Ekström,
M. Lehtihet,
M. Dahl,
2021,
International journal of qualitative studies on health and well-being.
L. Ekström,
M. Lehtihet,
M. Ericsson,
2020,
Drug testing and analysis.
R. Rylander,
J. Högberg,
A. Rannug,
1993,
FEBS letters.
J. Lindh,
G. Panagiotidis,
M. Dahl,
2007,
Therapeutic drug monitoring.
L. Bertilsson,
A. Llerena,
M. Dahl,
1993,
Psychopharmacology series.
L. Bertilsson,
M. Dahl,
L. Delbressine,
1997,
European Neuropsychopharmacology.
H. Druid,
J. Ahlner,
M. Dahl,
2004,
Journal of analytical toxicology.
J. Ahlner,
M. Reis,
F. Bengtsson,
2001,
Therapeutic drug monitoring.
B. Winblad,
M. Viitanen,
L. Lannfelt,
1998,
Alzheimer disease and associated disorders.
M. Reis,
F. Bengtsson,
M. Dahl,
2002,
Therapeutic drug monitoring.
E. Spina,
A. Gunes,
M. Dahl,
2008,
Therapeutic drug monitoring.
Leif Bertilsson,
M. Ingelman-Sundberg,
L. Bertilsson,
2006,
Clinical pharmacology and therapeutics.
E. Corruble,
R. Lanzenberger,
J. Meyer,
2021,
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
L. Ekström,
M. Lehtihet,
A. Rane,
2020,
Medicina.
L. Bertilsson,
M. Dahl,
1996
.
C. Alm,
L. Bertilsson,
A. Llerena,
1992,
Therapeutic drug monitoring.
J. Ahlner,
A. Odén,
J. Procházka,
2006,
Human psychopharmacology.
C. Alm,
L. Bertilsson,
M. Dahl,
2000,
Therapeutic drug monitoring.
A. Grahnén,
G. Alván,
G. Paintaud,
2006,
European Journal of Clinical Pharmacology.
L. Bertilsson,
K. Otani,
M. Dahl,
1991,
Pharmacology & toxicology.
M. Ingelman-Sundberg,
L. Bertilsson,
I. Johansson,
1993,
Proceedings of the National Academy of Sciences of the United States of America.
M Ingelman-Sundberg,
M. Ingelman-Sundberg,
J. Höög,
2001,
Pharmacogenetics.
C. Alm,
L. Bertilsson,
M. Dahl,
1996,
Clinical pharmacology and therapeutics.
Erik Eliasson,
Gunnel Tybring,
A. Llerena,
2002,
Clinical pharmacology and therapeutics.
Wei Wang,
E. Kolker,
E. Vayena,
2015,
Omics : a journal of integrative biology.
K. Melkersson,
M. Dahl,
2004,
Drugs.
M. Holtze,
S. Erhardt,
K. Linderholm,
2012,
Schizophrenia bulletin.
E. Kalso,
M. Dahl,
T. Heiskanen,
2002,
Pain.
E. Kalso,
M. Dahl,
T. Heiskanen,
2002
.
P. Deloukas,
P. Deloukas,
J. Lindh,
2010,
Clinical pharmacology and therapeutics.
Moustapha Hassan,
L. Griškevičius,
M. Dahl,
2003,
European Journal of Clinical Pharmacology.
A. Gunes,
M. Dahl,
2008,
Pharmacogenomics.
M. Dahl,
2002,
Clinical pharmacokinetics.
M Ingelman-Sundberg,
M. Ingelman-Sundberg,
L. Bertilsson,
1996,
Pharmacogenetics.
M. Ingelman-Sundberg,
L. Bertilsson,
I. Johansson,
1995,
The Journal of pharmacology and experimental therapeutics.
E. Molden,
M. Dahl,
T. Haslemo,
2012,
The Pharmacogenomics Journal.
Raúl Tabarés Gutiérrez,
Samit R. Joshi,
H. Jessen,
2016,
Journal of the International AIDS Society.
M. Ingelman-Sundberg,
U. Yasar,
I. Johansson,
1999,
Biochemical and biophysical research communications.
G. Lombardi,
G. Miglio,
M. Dahl,
2006,
European Journal of Clinical Pharmacology.
L. Ekström,
A. Rane,
M. Dahl,
2016,
Substance Abuse Treatment, Prevention, and Policy.
L. Bertilsson,
M. Dahl,
G. Tybring,
1995,
Pharmacogenetics.
E. Spina,
A. Gunes,
M. Dahl,
2008,
European Journal of Clinical Pharmacology.
K. Melkersson,
M. Dahl,
2012,
Drugs.
G. Lombardi,
G. Miglio,
M. Dahl,
2007,
European Neuropsychopharmacology.
K. Melkersson,
A. Gunes,
M. Dahl,
2010,
Human psychopharmacology.
K. Melkersson,
A. Gunes,
M. Dahl,
2009,
Journal of clinical psychopharmacology.
A. Gunes,
M. Dahl,
M. G. Scordo,
2007,
Psychopharmacology.
S. Kasper,
J. Brockmöller,
I. Roots,
2001,
Acta psychiatrica Scandinavica.
M. Ingelman-Sundberg,
U. Yasar,
M. Dahl,
2001,
Drug metabolism and disposition: the biological fate of chemicals.
I. Agartz,
L. Farde,
F. Piehl,
2018,
Schizophrenia Research.
B. Wettermark,
R. Berecz,
A. Llerena,
1998,
Scandinavian Journal of Infectious Diseases.
L. Bertilsson,
M. Dahl,
P. Dalén,
2002,
British journal of clinical pharmacology.
I. Schuppe-Koistinen,
S. Erhardt,
M. Samuelsson,
2014,
International journal of tryptophan research : IJTR.
M. Ingelman-Sundberg,
L. Bertilsson,
U. Meyer,
2004,
European Journal of Clinical Pharmacology.
L. Bertilsson,
M. Dahl,
P. Dalén,
1998,
Clinical pharmacology and therapeutics.
L. Ståhle,
G. Alván,
M. Dahl,
2001,
Clinical pharmacokinetics.
L. Bertilsson,
M. Dahl,
J. A. Carrillo,
2002,
Clinical pharmacology and therapeutics.
M. Ingelman-Sundberg,
L. Bertilsson,
M. Humble,
1993,
The Lancet.
L. Alfredsson,
J. Lindh,
A. Rane,
2008,
Journal of Thrombosis and Thrombolysis.
L. Bertilsson,
M. Eichelbaum,
M. Dahl,
2003,
British journal of clinical pharmacology.
E. Spina,
M. Dahl,
M. G. Scordo,
2002,
Clinical pharmacology and therapeutics.
Erik Eliasson,
Gunnel Tybring,
M. Dahl,
2001,
European Journal of Clinical Pharmacology.
M. Ingelman-Sundberg,
U. Yasar,
E. Spina,
2001,
British journal of clinical pharmacology.
M. Ingelman-Sundberg,
L. Bertilsson,
I. Johansson,
1999,
Pharmacogenetics.
C. Halldin,
L. Farde,
L. Bertilsson,
1995,
The American journal of psychiatry.
L. Bertilsson,
P. Edlund,
M. Dahl,
1998,
Drug metabolism and disposition: the biological fate of chemicals.
O. Spigset,
K. Hedenmalm,
R. Dahlqvist,
1997,
Acta psychiatrica Scandinavica.
C. Svensson,
I. Schuppe-Koistinen,
S. Erhardt,
2015,
Journal of psychiatry & neuroscience : JPN.
M. Eichelbaum,
M. Dahl,
F. Sjöqvist,
2018,
European Journal of Clinical Pharmacology.
M Ingelman-Sundberg,
M. Ingelman-Sundberg,
L. Bertilsson,
2001,
Drug metabolism and disposition: the biological fate of chemicals.
M. Dahl,
F. Sjöqvist,
2000,
Therapeutic drug monitoring.
U. Malm,
C. Halldin,
L. Farde,
1998,
The international journal of neuropsychopharmacology.
L. Bertilsson,
M. Dahl,
F. Sjöqvist,
1998,
Clinical pharmacology and therapeutics.
T. Marandi,
M. Dahl,
F. Sjöqvist,
1997,
European Journal of Clinical Pharmacology.
M. Dahl,
F. Sjöqvist,
M L Dahl,
1997,
Therapeutic drug monitoring.
M. Ingelman-Sundberg,
L. Bertilsson,
M. Eichelbaum,
1993,
Pharmacogenetics.
J. Ahlner,
M. Reis,
F. Bengtsson,
2002,
Journal of clinical psychopharmacology.
K. Melkersson,
A. Hulting,
M. Dahl,
2004,
Psychopharmacology.
U Bergman,
U. Bergman,
L. Gustafsson,
2002
.
Lack of association between debrisoquine 4‐hydroxylase (CYP2D6) gene polymorphisms and schizophrenia
G. Sedvall,
E. Jönsson,
M. Dahl,
1998,
Psychiatric genetics.
J. Stengård,
M. Ingelman-Sundberg,
O. Pelkonen,
1998,
FEBS letters.
M. Viitanen,
K. Johansson,
M. Dahl,
1997,
Journal of the American Geriatrics Society.
L. Bertilsson,
M. Anttila,
O. Pelkonen,
1998,
Clinical pharmacology and therapeutics.
K. Hedenmalm,
G. Alván,
M. Dahl,
2010,
Pharmacoepidemiology and drug safety.
A. Gunes,
M. Dahl,
M. G. Scordo,
2009,
Pharmacogenomics.
J. Ahlner,
M. Reis,
F. Bengtsson,
2009,
Clinical pharmacokinetics.
E. Spina,
M. Dahl,
M. G. Scordo,
2006,
Pharmacological research.
L. Bertilsson,
M. Dahl,
G. Tybring,
1998,
Scandinavian journal of gastroenterology.
M. Eriksson,
M. Dahl,
C. Nordin,
2002,
European Neuropsychopharmacology.
J. Franck,
M. Dahl,
Michel Arvidsson,
2019,
Nordic journal of psychiatry.
V. Manolopoulos,
G. Ragia,
M. Dahl,
2016,
Current drug metabolism.
T. Marandi,
M. Dahl,
J. Svensson,
2002,
Psychopharmacology.
L. Ekström,
M. Dahl,
A. Börjesson,
2021,
Frontiers in Reproductive Health.
C. Alm,
L. Bertilsson,
A. Massele,
1998,
Clinical pharmacology and therapeutics.
L. Ekström,
M. Lehtihet,
M. Dahl,
2021,
Frontiers in Sports and Active Living.
R. Malmström,
J. Lindh,
M. Dahl,
2013,
European Journal of Clinical Pharmacology.
K. Leander,
M. Vikström,
M. Dahl,
2021,
Scientific Reports.
A. Gunes,
M. Dahl,
2010,
Pharmaceuticals.
L. Bertilsson,
M. Eichelbaum,
M. Dahl,
1999,
Pharmacogenetics.
L. Bertilsson,
M. Dahl,
C. Nordin,
1991,
Therapeutic drug monitoring.
C. Masimirembwa,
L. Gustafsson,
M. Dahl,
2003,
British journal of clinical pharmacology.
C. Alm,
M. Ingelman-Sundberg,
L. Iselius,
1993,
European Journal of Clinical Pharmacology.
M. Dahl,
M. G. Scordo,
Ming Chang,
2015,
European Journal of Clinical Pharmacology.
M. Dahl,
M. L. Andersson,
C. Schörgenhofer,
2023,
Drugs & Aging.
M. Dahl,
M. M. Söderberg,
2013,
Pharmacogenomics.
S. Fallarini,
G. Lombardi,
M. Dahl,
2010,
European Journal of Clinical Pharmacology.
R. Gupta,
M. Samuelsson,
M. Dahl,
2009,
Amino Acids.
E N Jonsson,
M. Wadelius,
M. Dahl,
2007,
Clinical pharmacology and therapeutics.
K. Hedenmalm,
M. Dahl,
Arzu Gunes Granberg,
2014,
European Journal of Clinical Pharmacology.
L. Ekström,
J. Franck,
M. Dahl,
2022,
Basic & clinical pharmacology & toxicology.
M. Dahl,
O. Beck,
G. Ackehed,
2019,
European Journal of Clinical Pharmacology.
K. Melkersson,
A. Gunes,
M. Dahl,
2009,
Journal of clinical psychopharmacology.
K. Melkersson,
A. Gunes,
M. Dahl,
2010,
Human psychopharmacology.
M. Dahl,
P. Uotila,
M. Dahl,
1983,
Prostaglandins, leukotrienes, and medicine.